Nebivolol reduces central blood pressure in stage I hypertensive patients: experimental single cohort study

Nebivolol reduces central blood pressure in stage I hypertensive patients: experimental single cohort study

CONTEXT AND OBJECTIVES: Assessment of central blood pressure (BP) has grown substantially over recent years because evidence has shown that central BP is more relevant to cardiovascular outcomes than peripheral BP. Thus, different classes of antihypertensive drugs have different effects on central B...

Full description

Bibliographic Details
Main Authors: Renan Oliveira Vaz-de-Melo, Luiz Tadeu Giollo-Júnior, Débora Dada Martinelli, Heitor Moreno-Júnior, Marco Antônio Mota-Gomes, José Paulo Cipullo, Juan Carlos Yugar-Toledo, José Fernando Vilela-Martin
Format: Article
Language:English
Published: Associação Paulista de Medicina
Series:São Paulo Medical Journal
Subjects:
Adrenergic beta-antagonists
Vasodilator agents
Arterial pressure
Pulse wave analysis
Hypertension
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802014000500290&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802014000500290&lng=en&tlng=en

Similar Items